AMP vs NDAQ
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
AMP's deterministic health score is weak with a Piotroski F-Score of 4/9, indicating borderline financial stability. Despite strong profitability metrics like a 59.59% ROE and solid earnings growth (YoY +86.6%), the stock trades above its Graham defensive value of $235.33 at $496.60, reflecting rich valuation. Earnings volatility, declining recent estimate beats, and bearish insider activity offset strong cash flow efficiency and low leverage. Analysts concur with a 'hold' rating, aligning with technical bearishness and mixed fundamentals.
NDAQ presents a dichotomy between strong operational growth and bearish sentiment indicators. The Piotroski F-Score of 4/9 indicates stable but not strong financial health, while the current price of $86.37 trades at a massive premium to the Graham Number ($38.62) but remains slightly below the growth-based Intrinsic Value ($91.16). While earnings growth is exceptional (47.6% YoY) and margins are robust, the combination of a very low quick ratio (0.20), bearish insider selling by the CEO, and a 0/100 technical trend suggests significant near-term headwinds despite long-term fundamental strength.
Compare Another Pair
Related Comparisons
AMP vs NDAQ: Head-to-Head Comparison
This page compares Ameriprise Financial, Inc. (AMP) and Nasdaq, Inc. (NDAQ) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.